| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | G | Common Shares | Options Exercise | $1,935,500 | +70,000 | +43% | $27.65 | 233,049 | 12 Nov 2024 | Direct | F1 |
| transaction | G | Common Shares | Sale | $3,252,158 | -70,000 | -30% | $46.46 | 163,049 | 12 Nov 2024 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | G | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -70,000 | -100% | $0.000000 | 0 | 12 Nov 2024 | Common Shares | 70,000 | $27.65 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Includes 347 shares acquired under the Genpact Employee Stock Purchase Plan ("ESPP") since the reporting person's Form 4 filed on March 15, 2024. The reporting person currently holds a total of 9,689 shares under the ESPP. |
| F2 | The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $46.22 to $46.72. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
| F3 | The option vested 50% on January 10, 2019 and the remainder on January 10, 2021. |